Literature DB >> 17704358

Neurocognitive function in same-sex twins following focal radiation for medulloblastoma.

Donald J Mabbott1, Marcia Barnes, Normand Laperriere, Susan H Landry, Eric Bouffet.   

Abstract

Increased neurotoxicity and poor long-term neurocognitive outcome of preschool children treated for brain tumors have led to innovative therapeutic strategies in order to delay or avoid the use of craniospinal radiation and to improve survival. Because these protocols are relatively new, few data exist regarding cognitive outcome. We conducted a twin case-control study to investigate neurocognitive and behavioral outcome in a preschool patient who was 16 months old at diagnosis of medulloblastoma and was treated with surgery, chemotherapy, stem cell transplant, and focal radiation to the tumor bed. Stability and change over two assessments were compared for the patient and her nonaffected twin for standardized measures of cognitive function and experimental measures of parent-child interaction, social competence, and goal-directed play. A striking finding was improvement in intelligence, receptive language, and visual-motor functioning in the affected twin from 12 months to 24 months after treatment. Improvement in ratings of parent-child interaction and social competence for the affected twin was also evident. These findings are notable compared with the potentially devastating impact of craniospinal tumor, and this study is among the first to document the relative benefit of focal radiation in sparing cognitive function, albeit in a single case study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704358      PMCID: PMC1994104          DOI: 10.1215/15228517-2007-028

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  18 in total

1.  Early maternal and child influences on children's later independent cognitive and social functioning.

Authors:  S H Landry; K E Smith; P R Swank; C L Miller-Loncar
Journal:  Child Dev       Date:  2000 Mar-Apr

2.  Irradiated cerebellar medulloblastoma in a monozygotic twin. Growth, neurology and chromosomes 13 years after treatment.

Authors:  F Bodor; C H Håkansson; M Lindgren
Journal:  Acta Radiol Ther Phys Biol       Date:  1974-06

3.  Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.

Authors:  A W Walter; R K Mulhern; A Gajjar; R L Heideman; D Reardon; R A Sanford; X Xiong; L E Kun
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

Review 4.  Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study.

Authors:  D R Copeland; C deMoor; B D Moore; J L Ater
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

5.  Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies.

Authors:  Maryam Fouladi; Elizabeth Gilger; Mehmet Kocak; Dana Wallace; Gray Buchanan; Cara Reeves; Nicole Robbins; Thomas Merchant; Larry E Kun; Raja Khan; Amar Gajjar; Raymond Mulhern
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

6.  Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

Authors:  Jacques Grill; Christian Sainte-Rose; Anne Jouvet; Jean-Claude Gentet; Odile Lejars; Didier Frappaz; François Doz; Xavier Rialland; Fabienne Pichon; Anne-Isabelle Bertozzi; Pascal Chastagner; Dominique Couanet; Jean-Louis Habrand; Marie-Anne Raquin; Marie-Cécile Le Deley; Chantal Kalifa
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

7.  Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.

Authors:  J Grill; V K Renaux; C Bulteau; D Viguier; C Levy-Piebois; C Sainte-Rose; G Dellatolas; M A Raquin; I Jambaqué; C Kalifa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-08-01       Impact factor: 7.038

8.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

9.  A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.

Authors:  Regina I Jakacki; Hilary Feldman; Cheryl Jamison; Joel C Boaz; Thomas G Luerssen; Robert Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

Review 10.  Medulloblastoma: present concepts of stratification into risk groups.

Authors:  Roger J Packer; Brian R Rood; Tobey J MacDonald
Journal:  Pediatr Neurosurg       Date:  2003-07       Impact factor: 1.162

View more
  2 in total

1.  Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor.

Authors:  Rachael A Lester; Lindsay C Brown; Laurence J Eckel; Robert T Foote; Amulya A NageswaraRao; Jan C Buckner; Ian F Parney; Nicholas M Wetjen; Nadia N Laack
Journal:  J Neurooncol       Date:  2014-08-13       Impact factor: 4.130

2.  PCDH10 is a candidate tumour suppressor gene in medulloblastoma.

Authors:  Kelsey C Bertrand; Stephen C Mack; Paul A Northcott; Livia Garzia; Adrian Dubuc; Stefan M Pfister; James T Rutka; William A Weiss; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2011-05-20       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.